Quarter of survivors find life after cancer harder than actual treatment

life after cancer

Breast cancer patients often find it more difficult to cope with life after cancer that the actual treatment, a leading charity has found

New research from Breast Cancer Care suggests many survivors find treatment ending harder than having a breast removed or going through chemotherapy or radiotherapy.

From the survey, it was discovered that more than a quarter (26%) of women diagnosed with breast cancer say life after treatment is harder than the treatment itself.

Continue reading “Quarter of survivors find life after cancer harder than actual treatment”

Socialising with other cancer patients can help reduce stress

Researchers believe interacting with other people who are also having treatment reduces stress levels, leading to better survival prospects

Socialising with other cancer patients

Socialising with others who also have cancer, could potentially improve survival prospects, according to new research.

Patients undergoing chemotherapy who socialise with other sufferers have a 68% risk of dying within five years, scientists from the National Human Genome Research Institute have found.

This is compared to a 69.5% risk if patients are isolated from other sufferers during their treatment, the research adds.

Lead author Jeff Lienert, said: “A two percent difference in survival might not sound like a lot, but it’s pretty substantial. If you saw 5,000 patients in nine years, that two percent improvement would affect 100 people.”

Continue reading “Socialising with other cancer patients can help reduce stress”

Nigerian student develops new treatment for aggressive breast cancer

 Sandra Musujusu, breast cancer

A student in Africa has reportedly discovered an alternative treatment for an aggressive type of breast cancer.

 Sandra Musujusu, who studies at the University of Science and Technology in Abuja, Nigeria, is developing an alternative treatment for a subtype of breast cancer commonly found in black women. The Sierra Leone native’s research was unveiled earlier this month when World Bank director Jaime Saavedra Chanduvi visited the West African university as a part of his assessment tour of the 10 African Centers of Excellence locations, funded to encourage research to benefit African countries facing problems.

Continue reading “Nigerian student develops new treatment for aggressive breast cancer”

Groundbreaking cancer treatment close to approval By FDA

The ‘exciting’ breakthrough uses the body’s immune system to fight  the disease 

Scientists testing blood for prostate cancer

A new pioneering cancer treatment could be approved this autumn by America’s leading health agency.

The groundbreaking treatment, which uses the body’s own immune system to attack cancerous cells, is looking likely to be approved by the Food and Drug Administration (FDA).

The treatment, called CAR-T cell immunotherapy could be approved as early as the end of September after a unanimous approval from the agency’s Oncologic Drugs Advisory Committee.

Timothy Cripe, a panel member who is an oncologist with Nationwide Children’s Hospital in Columbus, Ohio, has sais the treatment the “most exciting thing I’ve seen in my lifetime.”

Continue reading “Groundbreaking cancer treatment close to approval By FDA”

Fall in ovarian cancer deaths worldwide linked to contraceptive pill use

ovarian cancer deaths

Ovarian cancer deaths have fallen around the world, largely because of the widespread use of the contraceptive pill, according to a major new study.

A study by Italian researchers has found that the number of people dying from ovarian cancer has dropped over the past decade due to increased use of the contraceptive pill together with a decline in the long-term use of hormone replacement therapy (HRT).

Continue reading “Fall in ovarian cancer deaths worldwide linked to contraceptive pill use”

Breast Cancer: New genomic test mans women could safely skip chemo

Doctor looks at scan

Tens of thousands of breast cancer patients could be saved from undergoing gruelling chemotherapy with a new test which shows whether drugs will be effective.

Many women with early stage breast cancer get no benefit from chemotherapy after having surgery and radiotherapy but some still receive treatment to be on the safe side.

Now a new test  has found to be effective at predicting which patients can be spared treatment.

MammaPrint is a new genomic test which scientists claim is able to accurately predict the risk of cancer recurrence for early-stage, hormone-receptor-positive and negative disease.

Continue reading “Breast Cancer: New genomic test mans women could safely skip chemo”

Scientists discover what could be a ‘perfect’ painkiller to replace morphine

New drug discovered by team including Nobel Prize-winning chemist shows ‘promise’ as a replacement for opium-based drugs like morphine

new pain killer to replace morphine

Scientists believe they may have found a new form of painkiller that works just as well as morphine but lacks its potentially lethal side effect and is not addictive.

A team that included Nobel Prize-winning chemist Professor Brian Kobilka, of Stanford University in the US have discovered a new compound that not only seems to be more effective than morphine in controlling pain, but also has fewer side effects too.

Cancer patients suffering from pain not controlled with the usual painkillers such as paracetamol and codeine may be prescribed morphine. Whilst this is a very effective drug it can also cause severe constipation, nausea and in extreme cases, if too much is taken, it can affect the brain’s breathing centre.

Continue reading “Scientists discover what could be a ‘perfect’ painkiller to replace morphine”

Hormone replacement therapy can triple risk of breast cancer

hormone replacement therapy

Hormone replacement therapy can triple the risk of breast cancer, the biggest ever study has found, following more than a decade of controversy.

Hormone replacement therapy (HRT) helps minimise the more troublesome symptoms of menopause such as hot flushes, disrupted sleep, migraines, mood changes and depression. That is why the National Institute of Health and Care Excellence (NICE), changed guidance to encourage more doctors to prescribe HRT claiming too many menopausal women had been left suffering in silence.

But doctors were reluctant to prescribe it after a study in 2002 suggested it could raise the risk of cancer, a claim later widely disputed. However, new findings by the Institute of Cancer Research and Breast Cancer Now suggest that these concerns were justified.

Continue reading “Hormone replacement therapy can triple risk of breast cancer”

Immunotherapy: Cancer’s newest treatment

Karen Koehler immunotherapy
Karen Koehler

When Karen Koehler was diagnosed with chronic lymphocytic leukemia in 2011, she was told not to worry. She had a mild case that could simply be monitored, her doctor said. But two years later, the cancer took a turn for the worse when a genetic mutation made it aggressive and difficult to treat with chemotherapy. “I was told I had 10 months to live,” said Koehler, 59, a retired teacher who lives in Park Ridge, New Jersey. At best, she was told, chemo might stretch that to two years.

Then Koehler was accepted into a clinical trial at Memorial Sloan Kettering Cancer Center in New York that aimed to turn her own immune cells into cancer killers. Within a month of treatment, her leukemia had vanished. “There were no cancer cells whatsoever,” said Koehler, who remains cancer-free today.

Continue reading “Immunotherapy: Cancer’s newest treatment”

Ovarian cancer test in sight as scientists find earliest signs of disease

Women could be tested for ovarian cancer in a similar way as doctors test for cervical cancer

ovarian cancer test

Ovarian cancer could be detected years before any symptoms emerge after scientists at Oxford University found a way to spot the first signs of the disease.

A study funded by Ovarian Cancer Action has discovered a protein that brings us closer to early detection and better treatment of Ovarian cancer. The discovery of the protein, SOX2, means that the disease could be spotted years before symptoms arise, giving women a better chance of successful treatment.

Continue reading “Ovarian cancer test in sight as scientists find earliest signs of disease”